Trial intelligence / Profile preview

IMULUS Fermented Milk and Influenza Vaccine Response

NCT02909842Completed

Sponsor
Mahidol University
Start
Jan 2016
Primary completion
Sep 2016
01

Overview

Randomised, triple-blind trial (2 arms), sponsored by Mahidol University. Primary endpoint: Immune response rate for H1N1, H3N2 and Phu-B virus. Started Jan 2016; status: completed.

Beyond the preview

Go deeper on NCT02909842.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02909842.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call